American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

Wrap-Up

Ribociclib Efficacious in Patients with Unresectable or HR-Positive/HER2-Negative Metastatic Breast Cancer Receiving Fulvestrant or Exemestane After Not Responding to Prior Treatments

ASCO 2022 – Wrap-Up

Patients with hormone receptor (HR)-positive/HER2-negative metastatic breast cancer who had previously advanced on any cyclin-dependent kinase (CDK)4/6 inhibitor plus any endocrine therapy (ET) showed a substantial progression-free survival (PFS) advantage in the ribociclib-treated cohort. Read More ›

Wrap-Up

Event-Free Survival by Residual Cancer Burden After Neoadjuvant Chemotherapy + Pembrolizumab for Early TNBC: KEYNOTE-522 Data

ASCO 2022 – Wrap-Up

Pembrolizumab plus chemotherapy increased event-free survival compared with chemotherapy alone, highlighting the relevance of neoadjuvant pembrolizumab therapy for improving survival in patients with early triple-negative breast cancer. Read More ›

Wrap-Up

Revised Overall Survival and Progression-Free Survival Data from the FAKTION Study: Capivasertib + Fulvestrant in Metastatic, ER-Positive Breast Cancer

ASCO 2022 – Wrap-Up

Capivasertib plus fulvestrant’s PFS advantage benefitted a broader patient population, and overall survival (OS) data with improved biomarker analyses can now be reported. Read More ›

Wrap-Up

Imlunestrant in ER-Positive Advanced Breast Cancer and Endometrial Endometrioid Cancer: EMBER Results

ASCO 2022 – Wrap-Up

Updated data from the EMBER trial of imlunestrant, a new oral selective estrogen receptor degrader showing sustained inhibition of estrogen receptor (ER)-dependent gene transcription and cell proliferation, have been released. Read More ›

Assessment of Oncology Patient Satisfaction with Telehealth Visits

ASCO 2021 – Breast Cancer

Telehealth visits provide increased access to care for oncology patients across multiple demographics with reported high patient satisfaction with level of care. Read More ›

Wrap-Up

Weight Gain in Breast Cancer Patients During Adjuvant Endocrine Therapy Linked to Menopausal Status

ASCO 2021 – Breast Cancer: Wrap-Up

Improved understanding of potential risk factors associated with weight gain will allow identification of at-risk patients and intervention for improved outcomes. Read More ›

Wrap-Up

Telemedicine Program Provides High-Quality Anticancer Medication Delivery and Management for Veterans

ASCO 2021 – Breast Cancer: Wrap-Up

The VA CARES program provides coordinated cancer care for veterans prescribed oral antineoplastic therapies who may lack access to comprehensive medication management resources. Read More ›

Wrap-Up

Real-Life Study of Alpelisib plus Fulvestrant Therapy After Treatment with CDK4/6 Inhibitor in French Breast Cancer Patients

ASCO 2021 – Breast Cancer: Wrap-Up

Alpelisib plus fulvestrant combination therapy improves progression-free survival while maintaining effectiveness in patients with HR-positive/HER2-negative advanced breast cancer in a French early access study. Read More ›

Wrap-Up

Implications for Use of Subjective Social Status as a Risk Factor for Metabolic Syndrome in Black Women with New Breast Cancer Diagnosis

ASCO 2021 – Breast Cancer: Wrap-Up

Metabolic syndrome is associated with poor prognosis in patients with breast cancer. Identifying potential risk factors for metabolic syndrome may improve outcomes in these women. Read More ›

Inflammatory Responses to Neoadjuvant Chemotherapy Can Be Regulated by Moderate Physical Exercise Prior to Surgery

ASCO 2021 – Breast Cancer

Moderate physical activity reduced the inflammatory response triggered by neoadjuvant chemotherapy in breast cancer patients prior to surgery. The benefit appears to be lost after surgery. Read More ›

American Society of Clinical Oncology (ASCO)

Page 6 of 33